Skip to content

Prenatal Screening, Diagnosis and Intrauterine Intervention of Fetal Abnormal Chromosome and Structure in Twins Pregnancy

Prenatal Screening, Diagnosis and Intrauterine Intervention of Fetal Abnormal Chromosome and Structure in Twins Pregnancy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02982356
Enrollment
1300
Registered
2016-12-05
Start date
2017-01-31
Completion date
2019-12-31
Last updated
2016-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chromosome Abnormality, Twin Pregnancy With Antenatal Problem

Brief summary

The risk of abnormal chromosome and structure is much higher in twins than in singletons, and traditional early pregnancy screening strategy for single pregnancy is not suitable for twins. Based on our management experience of fetal medicine at twin pregnancy, and multi-center cooperation, the study will carry out the following clinical studies: 1. to explore a suitable, early, noninvasive and accurate prenatal screening strategy for twin pregnancy. 2. fetal chromosomal abnormalities

Interventions

PROCEDUREFetal Selective Reduction Technology

Fetal Selective Reduction Technology will be conducted according to different gestational weeks: before 16weeks, 16\ 24 weeks, 24\ 27+6 weeks,\>28weeks

DRUGPotassium Chloride

Sponsors

Children's Hospital of Fudan University
CollaboratorOTHER
International Peace Maternity and Child Health Hospital
CollaboratorOTHER
Shanghai First Maternity and Infant Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* ultrasound diagnosis as twin pregnancy * at 11-14 gestational weeks

Exclusion criteria

* Multiple pregnancies (three or more) * Maternal history of chromosome aneuploidy abnormality or tumor

Design outcomes

Primary

MeasureTime frame
Success rate for the operation1 week

Secondary

MeasureTime frame
long-term complications after surgery1 year

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026